Keiretsu Forum Regions Demonstrate Investment Stability Amidst Industry-Wide Downturns
April 23, 2024 07:29 ET
|
Keiretsu Forum Mid-Atlantic
In 2023, Keiretsu Forum MA-SE-TX region’s curated investment portfolio maintained a confident stance within an otherwise retreating investment ecosystem.
Acri Capital Acquisition Corporation Announces Confidential Submission of Draft Registration Statement on Form S-4 and Extension of the Deadline for an Initial Business Combination
April 10, 2024 16:30 ET
|
Acri Capital Acquisition Corporation
Austin, Texas, April 10, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in relation to its...
Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
March 13, 2024 16:05 ET
|
Acri Capital Acquisition Corporation
Austin, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the “Company”) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in order to extend...
Fundbox Appoints Ram Muthaiyan as Chief Risk & Product Officer
March 04, 2024 16:23 ET
|
Fundbox
Fundbox, the leading embedded working capital platform for small businesses, announces Ram Muthaiyan as new Chief Risk & Product Officer.
Bitcoin Well Provides Preliminary Year End Update and Bitcoin Super Company Vision
February 21, 2024 08:35 ET
|
Bitcoin Well
Preliminary, unaudited Q4 growth numbers for Bitcoin Well and Bitcoin Super Company vision outline.
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 06, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
January 23, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Morgan Gustafson Promoted to Jr. Art Director at Hummingbird Creative Group
January 16, 2024 15:37 ET
|
Hummingbird Creative Group
Cary, North Carolina, USA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Hummingbird Creative Group, a brand strategy and creative agency in Cary, North Carolina, announced the promotion of Morgan Gustafson to...
Keiretsu Forum’s Investor Capital Expo Highlights Resilience and Opportunity in Early-Stage Investments
October 30, 2023 08:12 ET
|
Keiretsu Forum Mid-Atlantic
PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- In the wake of six consecutive quarters marked by market correction affecting mid and late-stage investments, 2023 witnessed a notable contraction in...